Although inhibitors of the enzymatic hydrolysis of the endocannabinoid 2-arachidonoylglycerol are available, they are either rather weak in vitro (IC(50) > 30 mu M) or their selectivity towards other proteins of the endocannabinoid system has not been tested. Here we describe the synthesis and activity in vitro and in vivo of a tetrahydrolipstatin analogue, OMDM169, as a potent inhibitor of 2-AG hydrolysis, capable of enhancing 2-AG levels and of exerting analgesic activity via indirect activation of cannabinoid receptors. OMDM169 exhibited 0.13 mu M < IC(50) < 0.41 mu M towards 2-AG hydrolysing activities in COS-7 cells and rat cerebellum, and inhibited (IC(50) = 0.89 mu M) the human recombinant MAGI, whilst being inactive (K(i) > 10 mu M) at human CB(1) and CB(2) receptors. However, OMDM169 shared with tetrahydrolipstatin the capability of inhibiting the human pancreatic lipase (IC(50) = 0.6 mu M). OMDM169 inhibited fatty acid amide hydrolase and diacylglycerol lipase only at higher concentrations (IC(50) = 3.0 and 2.8 mu M, respectively), and, accordingly, it increased by similar to 1.6-fold the levels of 2-AG, but not anandamide, in intact ionomycin-stimulated N18TG2 neuroblastoma cells. Acute intraperitoneal (i.p.) administration of OMDM169 to mice inhibited the second phase of the formalin-induced nocifensive response with an IC(50) of similar to 2.5 mg/kg, and concomitantly elevated 2-AG, but not anandamide, levels in the ipsilateral paw of formalin-treated mice. The antinociceptive effect of OMDM169 was antagonized by antagonists of CB(1) and CB(2) receptors, AM251 and AM630, respectively (1 mg/kg, i.p.). OMDM69 might represent a template for the development of selective and even more potent inhibitors of 2-AG hydrolysis. (C) 2008 Elsevier B.V. All rights reserved.

Development of a potent inhibitor of 2-arachidonoylglycerol hydrolysis with antinociceptive activity in vivo / Tiziana, Bisogno; Ortar, Giorgio; Stefania, Petrosino; Morera, Enrico; Enza, Palazzo; Nalli, Marianna; Sabatino, Maione; Vincenzo Di, Marzo. - In: BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS. - ISSN 1388-1981. - 1791:1(2009), pp. 53-60. [10.1016/j.bbalip.2008.10.007]

Development of a potent inhibitor of 2-arachidonoylglycerol hydrolysis with antinociceptive activity in vivo

ORTAR, Giorgio;MORERA, ENRICO;NALLI, Marianna;
2009

Abstract

Although inhibitors of the enzymatic hydrolysis of the endocannabinoid 2-arachidonoylglycerol are available, they are either rather weak in vitro (IC(50) > 30 mu M) or their selectivity towards other proteins of the endocannabinoid system has not been tested. Here we describe the synthesis and activity in vitro and in vivo of a tetrahydrolipstatin analogue, OMDM169, as a potent inhibitor of 2-AG hydrolysis, capable of enhancing 2-AG levels and of exerting analgesic activity via indirect activation of cannabinoid receptors. OMDM169 exhibited 0.13 mu M < IC(50) < 0.41 mu M towards 2-AG hydrolysing activities in COS-7 cells and rat cerebellum, and inhibited (IC(50) = 0.89 mu M) the human recombinant MAGI, whilst being inactive (K(i) > 10 mu M) at human CB(1) and CB(2) receptors. However, OMDM169 shared with tetrahydrolipstatin the capability of inhibiting the human pancreatic lipase (IC(50) = 0.6 mu M). OMDM169 inhibited fatty acid amide hydrolase and diacylglycerol lipase only at higher concentrations (IC(50) = 3.0 and 2.8 mu M, respectively), and, accordingly, it increased by similar to 1.6-fold the levels of 2-AG, but not anandamide, in intact ionomycin-stimulated N18TG2 neuroblastoma cells. Acute intraperitoneal (i.p.) administration of OMDM169 to mice inhibited the second phase of the formalin-induced nocifensive response with an IC(50) of similar to 2.5 mg/kg, and concomitantly elevated 2-AG, but not anandamide, levels in the ipsilateral paw of formalin-treated mice. The antinociceptive effect of OMDM169 was antagonized by antagonists of CB(1) and CB(2) receptors, AM251 and AM630, respectively (1 mg/kg, i.p.). OMDM69 might represent a template for the development of selective and even more potent inhibitors of 2-AG hydrolysis. (C) 2008 Elsevier B.V. All rights reserved.
2009
2-arachidonoylglycerol; anandamide; cannabinoid receptor; diacylglycerol lipase; endocannabinoid; fatty acid amide hydrolase; inhibitor; monoacylglycerol lipase; pain
01 Pubblicazione su rivista::01a Articolo in rivista
Development of a potent inhibitor of 2-arachidonoylglycerol hydrolysis with antinociceptive activity in vivo / Tiziana, Bisogno; Ortar, Giorgio; Stefania, Petrosino; Morera, Enrico; Enza, Palazzo; Nalli, Marianna; Sabatino, Maione; Vincenzo Di, Marzo. - In: BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS. - ISSN 1388-1981. - 1791:1(2009), pp. 53-60. [10.1016/j.bbalip.2008.10.007]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/227466
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 27
  • Scopus 66
  • ???jsp.display-item.citation.isi??? 64
social impact